- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05736510
Brainwave Entrainment During Emergence (BB_emergence)
The Effect of Binaural Sound on Recovery of General Anesthesia in Patients Undergoing Laparoscopic Simple Gynecological Surgery
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
After entering the operating room, electrocardiogram, pulse oxygen saturation, blood pressure meter, and sedline are attached to start monitoring vital signs and patient state index (PSI). propofol and the remifentanil continuous infusion device is connected as close as possible to the catheter insertion site. Anesthesia is induced with total intravenous anesthesia (4 ng/mL of Remifentanil, 4 mg/mL of propofol). Rocuronium is administered after checking the patient's unconsciousness. When appropriate neuromuscular blocking is reached, tracheal intubation is performed. The anesthesia maintenance is performed to keep stable vital sign and PSI between 25 and 50. End-tidal carbon dioxide is controlled to be between 30 mmHg and 40 mmHg.
When the pneumoperitoneum ends, the propofol concentration is recorded (T0). The anesthesiologist in charge of anesthesia puts headphones on the patient and plays the allocated file. The allocated file is named the screening number. Depending on the allocated group, the audio file is binaural sound for the experimental group, and a silent file for the control group.
The anesthesiologist cannot know group allocation, since the length and size of files are the same. Thereafter, the target of PSI is to be between 40 and 50. If the Psi increases above 50, increase the propofol concentration by 0.5 mg/mL and record it. Train of four counts keep between 1 to 3 (moderate block). When the operation is ended, stop anesthetics administration, and record the time (T1). At the same time, the investigators reverse neuromuscular blocking using sugammadex (2mg/ kg).
When the anesthesiologist starts waking the patient up, call the patient's name (unify into "OOO, open your eyes."). The anesthesiologist lightly tap the patient's shoulder and avoid excessive sound or stimulation.
Record the time (T2) when the PSI reaches 50, the time when the patient opens eyes (T3), and the time (T4) when the extubation of endotracheal tube was done. T3-T1 is the time it took the patient to open his eyes (primary end point). Write the effect site concentration of propofol and remifentanil recorded for each time points.
The patient's sedline EEG data from the end of pneumoperitoneum until the patient's exit operating room is collected as raw data. The patient's blood pressure and heart rate are measured at each time points. The investigators evaluate sedation and agitation of the patients using Ramsay Sedation Scale.
In the post-anesthesia care unit, pain score (NRS 0-10), postoperative nausea vomiting, medication, and length of stay are investigated.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Seoul, Korea, Republic of
- Seoul National University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients between 19 and 50 years of age who are scheduled to undergo laparoscopic salpingo-oophorectomy/ ovarian cystectomy
- Intellectual level to understand the procedures of the clinical trial
- Physical status classification of the American Society of Anesthesiology (ASA) 1-2 grades
Exclusion Criteria:
- Patients with hearing loss or using hearing aids
- Patients who have been given narcotic painkillers or sedative drugs within a week.
- Alcohol-dependent or drug-dependent patients
- Patients with drug hypersensitivity to anesthetics
- Patients with arrhythmia, cardiovascular disease, impaired heart function, decreased circulatory blood flow
- Patients with liver failure
- Patients with other major medical or psychological disorder that will affect the treatment response
- Patients with claustrophobia or anxiety disorder
- Patients with organic brain disorders or other conditions that cannot be properly measured by PSI
- Patients who have been newly diagnosed with myocardial infarction, cerebral ischemic seizure, stroke, clinically significant coronary artery disease, or have undergone percutaneous carotid coronary dilatation or coronary bypass treatment within 6 months
- Patients with a history of epilepsy or seizures
- Patients with acute angle glaucoma
- Patients who deemed unsuitable for this clinical trial
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Binaural
Exposed to binaural sound (40 Hz) from the end of pneumoperitoneum until the eyes are open
|
When the pneumoperitoneum ends, the anesthesiologist puts headphones on the patient and plays the allocated file.
In the experimental group, the allocated file is binaural sound with 40Hz beat.
Thereafter, the target of PSI is to be between 40 and 50.
If the Psi increases above 50, increase the propofol concentration by 0.5 mg/mL and record it.
Train of four counts keep between 1 to 3 (moderate block).
When the operation is ended, stop anesthetics administration, and, we reverse neuromuscular blocking using sugammadex (2mg/ kg).
When the anesthesiologist starts waking the patient up, call the patient's name (unify into "OOO, open your eyes.").
The anesthesiologist lightly tap the patient's shoulder and avoid excessive sound or stimulation.
|
|
Active Comparator: Control
Applied silent files from the end of pneumoperitoneum until the eyes are open
|
When the pneumoperitoneum ends, the anesthesiologist puts headphones on the patient and plays the allocated file.
In the control group, the allocated file is silent.
Thereafter, the target of PSI is to be between 40 and 50.
If the Psi increases above 50, increase the propofol concentration by 0.5 mg/mL and record it.
Train of four counts keep between 1 to 3 (moderate block).
When the operation is ended, stop anesthetics administration, and, we reverse neuromuscular blocking using sugammadex (2mg/ kg).
When the anesthesiologist starts waking the patient up, call the patient's name (unify into "OOO, open your eyes.").
The anesthesiologist lightly tap the patient's shoulder and avoid excessive sound or stimulation.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Eye opening time
Time Frame: after the anesthetic infusion is terminated until 1 hour
|
The time it takes to open patient's eyes in response to the voice after the anesthetic infusion is terminated.
|
after the anesthetic infusion is terminated until 1 hour
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Extubation time
Time Frame: after the anesthetic infusion is terminated until 1 hour
|
The time it takes from the end of the anesthetic infusion to the extubation of endotracheal tube
|
after the anesthetic infusion is terminated until 1 hour
|
|
Systolic blood pressure
Time Frame: from the end of the anesthetic infusion to the exit of operating room until 1 hour
|
Noninvasive systolic blood pressure
|
from the end of the anesthetic infusion to the exit of operating room until 1 hour
|
|
Diastolic blood pressure
Time Frame: from the end of the anesthetic infusion to the exit of operating room until 1 hour
|
Noninvasive diastolic blood pressure
|
from the end of the anesthetic infusion to the exit of operating room until 1 hour
|
|
Mean blood pressure
Time Frame: from the end of the anesthetic infusion to the exit of operating room until 1 hour
|
Noninvasive mean blood pressure
|
from the end of the anesthetic infusion to the exit of operating room until 1 hour
|
|
Heart rate
Time Frame: from the end of the anesthetic infusion to the exit of operating room until 1 hour
|
Heart rate
|
from the end of the anesthetic infusion to the exit of operating room until 1 hour
|
|
alpha band activity
Time Frame: from the end of the anesthetic infusion to the exit of operating room until 1 hour
|
alpha band activity of electroencephalogram from Sedline data
|
from the end of the anesthetic infusion to the exit of operating room until 1 hour
|
|
beta band activity
Time Frame: from the end of the anesthetic infusion to the exit of operating room until 1 hour
|
beta band activity of electroencephalogram from Sedline data
|
from the end of the anesthetic infusion to the exit of operating room until 1 hour
|
|
theta band activity
Time Frame: from the end of the anesthetic infusion to the exit of operating room until 1 hour
|
theta band activity of electroencephalogram from Sedline data
|
from the end of the anesthetic infusion to the exit of operating room until 1 hour
|
|
delta band activity
Time Frame: from the end of the anesthetic infusion to the exit of operating room until 1 hour
|
delta band activity of electroencephalogram from Sedline data
|
from the end of the anesthetic infusion to the exit of operating room until 1 hour
|
|
Ramsay Sedation Scale
Time Frame: When the end of anesthesia within 5minutes
|
The degree of patient's sedation or agitation (1 to 6: 1 means "Patient is anxious and agitated or restless, or both"; 6 means "Patient exhibits no response")
|
When the end of anesthesia within 5minutes
|
|
Postoperative recovery score
Time Frame: When the patient stay in post-anesthesia care unit up to 1 hour
|
Postoperative recovery score (0-10; activity (0-2), respiration (0-2), circulation (0-2), consciousness level (0-2), and color (0-2); optimum score 10)
|
When the patient stay in post-anesthesia care unit up to 1 hour
|
|
Pain score
Time Frame: When the patient stay in post-anesthesia care unit up to 1 hour
|
Postoperative pain score using numeric rating scale(0-10: 0, no pain; 10, worst possible pain)
|
When the patient stay in post-anesthesia care unit up to 1 hour
|
|
Rate of postoperative nausea and vomiting
Time Frame: When the patient stay in post-anesthesia care unit up to 1 hour
|
Rate of postoperative nausea and vomiting
|
When the patient stay in post-anesthesia care unit up to 1 hour
|
|
Length of stay in post-anesthesia care unit
Time Frame: From entering to exit the post-anesthesia care unit up to 2 hours
|
Length of stay in post-anesthesia care unit
|
From entering to exit the post-anesthesia care unit up to 2 hours
|
|
Medication
Time Frame: When the patient stay in post-anesthesia care unit up to 1 hour
|
Rate of administration of any medication in post-anesthesia care unit
|
When the patient stay in post-anesthesia care unit up to 1 hour
|
Collaborators and Investigators
Publications and helpful links
General Publications
- Schmid W, Marhofer P, Opfermann P, Zadrazil M, Kimberger O, Triffterer L, Marhofer D, Klug W. Brainwave entrainment to minimise sedative drug doses in paediatric surgery: a randomised controlled trial. Br J Anaesth. 2020 Sep;125(3):330-335. doi: 10.1016/j.bja.2020.05.050. Epub 2020 Jul 8.
- Ozkose Z, Yalcin Cok O, Tuncer B, Tufekcioglu S, Yardim S. Comparison of hemodynamics, recovery profile, and early postoperative pain control and costs of remifentanil versus alfentanil-based total intravenous anesthesia (TIVA). J Clin Anesth. 2002 May;14(3):161-8. doi: 10.1016/s0952-8180(01)00368-3.
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2212-028-1383
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.